Spain

Spain

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.75 (0.67 - 0.83) 2019 Modelled IHME
0.76 (0.68 - 0.83) 2018 Modelled IHME
0.76 (0.69 - 0.84) 2017 Modelled IHME
0.79 (0.70 - 0.87) 2016 Modelled IHME
0.81 (0.72 - 0.90) 2015 Modelled IHME
0.82 (0.73 - 0.91) 2014 Modelled IHME
0.83 (0.75 - 0.91) 2013 Modelled IHME
0.84 (0.75 - 0.93) 2012 Modelled IHME
0.85 (0.76 - 0.94) 2011 Modelled IHME
0.86 (0.76 - 0.95) 2010 Modelled IHME
0.87 (0.78 - 0.96) 2009 Modelled IHME
0.88 (0.79 - 0.97) 2008 Modelled IHME
0.89 (0.80 - 0.99) 2007 Modelled IHME
0.9 (0.81 - 1) 2006 Modelled IHME
0.91 (0.82 - 1.02) 2005 Modelled IHME
0.92 (0.83 - 1.03) 2004 Modelled IHME
0.93 (0.84 - 1.03) 2003 Modelled IHME
0.94 (0.84 - 1.04) 2002 Modelled IHME
0.95 (0.85 - 1.05) 2001 Modelled IHME
0.96 (0.85 - 1.07) 2000 Modelled IHME
0.97 (0.87 - 1.07) 1999 Modelled IHME
0.98 (0.88 - 1.08) 1998 Modelled IHME
0.99 (0.89 - 1.09) 1997 Modelled IHME
1 (0.89 - 1.10) 1996 Modelled IHME
1.01 (0.90 - 1.12) 1995 Modelled IHME
1.02 (0.91 - 1.12) 1994 Modelled IHME
1.02 (0.93 - 1.13) 1993 Modelled IHME
1.03 (0.93 - 1.15) 1992 Modelled IHME
1.04 (0.94 - 1.16) 1991 Modelled IHME
1.05 (0.95 - 1.18) 1990 Modelled IHME
0 (0 - 1) 2003 Survey/reported Lopez-Izquierdo R et al, 2007
1.4 (0.80 - 2.20) 2002 Survey/reported Salleras L et al, 2007
0.7 (0.50 - 1) 2009 Survey/reported Pedraza-Flechas et al, 2014
0.8 (0.60 - 1.10) 2016 Modelled ECDC
0.57 (0.44 - 0.72) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.03 (0.02 - 0.04) 2019 Modelled IHME
0.03 (0.02 - 0.04) 2018 Modelled IHME
0.03 (0.02 - 0.04) 2017 Modelled IHME
0.03 (0.02 - 0.04) 2016 Modelled IHME
0.03 (0.02 - 0.04) 2015 Modelled IHME
0.03 (0.02 - 0.04) 2014 Modelled IHME
0.03 (0.02 - 0.04) 2013 Modelled IHME
0.03 (0.02 - 0.04) 2012 Modelled IHME
0.03 (0.02 - 0.04) 2011 Modelled IHME
0.03 (0.02 - 0.04) 2010 Modelled IHME
0.03 (0.02 - 0.04) 2009 Modelled IHME
0.03 (0.02 - 0.04) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.03 (0.03 - 0.05) 2006 Modelled IHME
0.04 (0.03 - 0.05) 2005 Modelled IHME
0.04 (0.03 - 0.06) 2004 Modelled IHME
0.06 (0.04 - 0.07) 2003 Modelled IHME
0.07 (0.05 - 0.10) 2002 Modelled IHME
0.09 (0.06 - 0.12) 2001 Modelled IHME
0.1 (0.07 - 0.13) 2000 Modelled IHME
0.1 (0.07 - 0.13) 1999 Modelled IHME
0.1 (0.08 - 0.14) 1998 Modelled IHME
0.1 (0.08 - 0.14) 1997 Modelled IHME
0.11 (0.08 - 0.14) 1996 Modelled IHME
0.11 (0.08 - 0.14) 1995 Modelled IHME
0.13 (0.10 - 0.17) 1994 Modelled IHME
0.18 (0.13 - 0.23) 1993 Modelled IHME
0.24 (0.18 - 0.31) 1992 Modelled IHME
0.33 (0.24 - 0.41) 1991 Modelled IHME
0.41 (0.30 - 0.53) 1990 Modelled IHME
0.19 (0.12 - 0.27) 2015 Modelled WHO
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.55 2017 Survey/reported ECDC Monitoring Report
Pregnant women
Download
Value (%) Year Type Source
0.1 (0 - 0.50) 2009 Survey/reported Salleras L et al, 2009
Prisoners
Download
Value (%) Year Type Source
2.6 (0.80 - 4.50) 2008 Survey/reported Garcia-Guerrero J et al, 2010

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.07 (1.59 - 2.63) 2019 Modelled IHME
2.06 (1.59 - 2.62) 2018 Modelled IHME
2.05 (1.58 - 2.62) 2017 Modelled IHME
2.03 (1.56 - 2.60) 2016 Modelled IHME
2.04 (1.58 - 2.59) 2015 Modelled IHME
2.01 (1.57 - 2.55) 2014 Modelled IHME
2.03 (1.59 - 2.55) 2013 Modelled IHME
2.07 (1.64 - 2.61) 2012 Modelled IHME
2.09 (1.66 - 2.63) 2011 Modelled IHME
2.11 (1.68 - 2.64) 2010 Modelled IHME
2.15 (1.71 - 2.70) 2009 Modelled IHME
2.2 (1.75 - 2.74) 2008 Modelled IHME
2.26 (1.79 - 2.81) 2007 Modelled IHME
2.29 (1.83 - 2.87) 2006 Modelled IHME
2.36 (1.87 - 2.96) 2005 Modelled IHME
2.51 (2 - 3.14) 2004 Modelled IHME
2.8 (2.24 - 3.51) 2003 Modelled IHME
3.09 (2.47 - 3.86) 2002 Modelled IHME
3.33 (2.67 - 4.16) 2001 Modelled IHME
3.47 (2.78 - 4.34) 2000 Modelled IHME
3.57 (2.85 - 4.44) 1999 Modelled IHME
3.57 (2.85 - 4.46) 1998 Modelled IHME
3.57 (2.87 - 4.44) 1997 Modelled IHME
3.63 (2.92 - 4.49) 1996 Modelled IHME
3.63 (2.92 - 4.51) 1995 Modelled IHME
3.64 (2.92 - 4.50) 1994 Modelled IHME
3.67 (2.94 - 4.54) 1993 Modelled IHME
3.72 (2.95 - 4.60) 1992 Modelled IHME
3.79 (3.01 - 4.74) 1991 Modelled IHME
3.81 (2.99 - 4.84) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
954 (732 - 1,212) 2019 Modelled IHME
951 (733 - 1,210) 2018 Modelled IHME
950 (732 - 1,217) 2017 Modelled IHME
945 (728 - 1,208) 2016 Modelled IHME
953 (738 - 1,208) 2015 Modelled IHME
945 (734 - 1,198) 2014 Modelled IHME
955 (747 - 1,201) 2013 Modelled IHME
977 (772 - 1,229) 2012 Modelled IHME
988 (781 - 1,241) 2011 Modelled IHME
993 (787 - 1,242) 2010 Modelled IHME
1,005 (797 - 1,257) 2009 Modelled IHME
1,016 (805 - 1,265) 2008 Modelled IHME
1,026 (812 - 1,277) 2007 Modelled IHME
1,029 (819 - 1,285) 2006 Modelled IHME
1,043 (827 - 1,307) 2005 Modelled IHME
1,091 (867 - 1,364) 2004 Modelled IHME
1,198 (957 - 1,498) 2003 Modelled IHME
1,299 (1,036 - 1,621) 2002 Modelled IHME
1,379 (1,103 - 1,721) 2001 Modelled IHME
1,415 (1,134 - 1,771) 2000 Modelled IHME
1,439 (1,151 - 1,792) 1999 Modelled IHME
1,427 (1,142 - 1,784) 1998 Modelled IHME
1,416 (1,139 - 1,762) 1997 Modelled IHME
1,434 (1,154 - 1,775) 1996 Modelled IHME
1,428 (1,149 - 1,772) 1995 Modelled IHME
1,426 (1,145 - 1,762) 1994 Modelled IHME
1,435 (1,148 - 1,772) 1993 Modelled IHME
1,449 (1,150 - 1,790) 1992 Modelled IHME
1,474 (1,169 - 1,843) 1991 Modelled IHME
1,479 (1,161 - 1,877) 1990 Modelled IHME
1,610 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
9 (6 - 14) 2019 Modelled IHME
9 (7 - 14) 2018 Modelled IHME
10 (7 - 14) 2017 Modelled IHME
10 (7 - 14) 2016 Modelled IHME
10 (7 - 14) 2015 Modelled IHME
10 (7 - 14) 2014 Modelled IHME
10 (7 - 14) 2013 Modelled IHME
10 (7 - 14) 2012 Modelled IHME
9 (7 - 14) 2011 Modelled IHME
9 (7 - 14) 2010 Modelled IHME
10 (7 - 14) 2009 Modelled IHME
10 (7 - 14) 2008 Modelled IHME
10 (7 - 14) 2007 Modelled IHME
10 (7 - 14) 2006 Modelled IHME
10 (7 - 14) 2005 Modelled IHME
10 (7 - 14) 2004 Modelled IHME
10 (7 - 14) 2003 Modelled IHME
10 (7 - 15) 2002 Modelled IHME
10 (7 - 15) 2001 Modelled IHME
10 (7 - 15) 2000 Modelled IHME
10 (7 - 15) 1999 Modelled IHME
10 (7 - 15) 1998 Modelled IHME
10 (7 - 15) 1997 Modelled IHME
10 (7 - 15) 1996 Modelled IHME
10 (7 - 15) 1995 Modelled IHME
10 (7 - 15) 1994 Modelled IHME
11 (7 - 15) 1993 Modelled IHME
11 (7 - 15) 1992 Modelled IHME
11 (7 - 15) 1991 Modelled IHME
11 (7 - 15) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
94 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
95 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
97 2010 Survey/reported WHO/UNICEF
96 2009 Survey/reported WHO/UNICEF
97 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
97 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
97 2004 Survey/reported WHO/UNICEF
81 2003 Survey/reported WHO/UNICEF
82 2002 Survey/reported WHO/UNICEF
83 2001 Survey/reported WHO/UNICEF
77 2000 Survey/reported WHO/UNICEF
80 1999 Survey/reported WHO/UNICEF
81 1998 Survey/reported WHO/UNICEF
84 1997 Survey/reported WHO/UNICEF
82 1996 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
119 2016 Survey/reported EMCDDA, 2019
141 (84 - 428) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
Yes
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.98 (0.79 - 1.18) 2019 Modelled IHME
0.97 (0.79 - 1.18) 2018 Modelled IHME
0.96 (0.79 - 1.18) 2017 Modelled IHME
0.95 (0.78 - 1.17) 2016 Modelled IHME
0.95 (0.77 - 1.17) 2015 Modelled IHME
0.95 (0.77 - 1.17) 2014 Modelled IHME
0.95 (0.78 - 1.17) 2013 Modelled IHME
0.96 (0.78 - 1.17) 2012 Modelled IHME
0.96 (0.78 - 1.18) 2011 Modelled IHME
0.97 (0.78 - 1.18) 2010 Modelled IHME
0.95 (0.77 - 1.15) 2009 Modelled IHME
0.89 (0.74 - 1.07) 2008 Modelled IHME
0.83 (0.70 - 0.99) 2007 Modelled IHME
0.78 (0.66 - 0.92) 2006 Modelled IHME
0.76 (0.65 - 0.89) 2005 Modelled IHME
0.77 (0.66 - 0.90) 2004 Modelled IHME
0.8 (0.69 - 0.93) 2003 Modelled IHME
0.84 (0.72 - 0.98) 2002 Modelled IHME
0.88 (0.75 - 1.02) 2001 Modelled IHME
0.91 (0.77 - 1.06) 2000 Modelled IHME
0.93 (0.79 - 1.09) 1999 Modelled IHME
0.96 (0.80 - 1.12) 1998 Modelled IHME
0.98 (0.82 - 1.16) 1997 Modelled IHME
0.99 (0.83 - 1.18) 1996 Modelled IHME
1 (0.83 - 1.20) 1995 Modelled IHME
1 (0.83 - 1.18) 1994 Modelled IHME
1 (0.83 - 1.18) 1993 Modelled IHME
0.99 (0.83 - 1.19) 1992 Modelled IHME
0.98 (0.82 - 1.17) 1991 Modelled IHME
0.96 (0.80 - 1.16) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.4 (0 - 2.30) 2015 Survey/reported Garcia-Alonso, 2016
1.1 (0.30 - 2.80) 2003 Survey/reported Lopez-Izquierdo R et al, 2007
1.7 (0.40 - 2.60) 2014 Modelled Gower et al, 2014
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
2 2017 Survey/reported ECDC
People who inject drugs (PWID)
Download
Value (%) Year Type Source
71 (69.50 - 72.50) 2012 Modelled Degenhardt L et al, 2017
Pregnant women
Download
Value (%) Year Type Source
0.2 (0.10 - 0.30) 2012 Survey/reported Seisdedos T et al, 2011
Prisoners
Download
Value (%) Year Type Source
20.3 (18.90 - 21.70) 2009 Modelled ECDC

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
10.5 (8.76 - 12.20) 2019 Modelled IHME
10.4 (8.63 - 12.10) 2018 Modelled IHME
10.3 (8.50 - 12.10) 2017 Modelled IHME
10.2 (8.51 - 12) 2016 Modelled IHME
10.2 (8.49 - 11.90) 2015 Modelled IHME
9.97 (8.34 - 11.70) 2014 Modelled IHME
9.89 (8.27 - 11.60) 2013 Modelled IHME
9.9 (8.28 - 11.60) 2012 Modelled IHME
9.83 (8.21 - 11.50) 2011 Modelled IHME
9.78 (8.16 - 11.50) 2010 Modelled IHME
9.87 (8.23 - 11.60) 2009 Modelled IHME
9.96 (8.30 - 11.70) 2008 Modelled IHME
10.1 (8.35 - 11.90) 2007 Modelled IHME
10.1 (8.39 - 12) 2006 Modelled IHME
10.3 (8.62 - 12.20) 2005 Modelled IHME
10.5 (8.73 - 12.40) 2004 Modelled IHME
10.6 (8.80 - 12.60) 2003 Modelled IHME
10.5 (8.73 - 12.50) 2002 Modelled IHME
10.4 (8.62 - 12.40) 2001 Modelled IHME
10.4 (8.60 - 12.40) 2000 Modelled IHME
10.5 (8.74 - 12.60) 1999 Modelled IHME
10.4 (8.66 - 12.40) 1998 Modelled IHME
10.3 (8.57 - 12.40) 1997 Modelled IHME
10.3 (8.52 - 12.40) 1996 Modelled IHME
10.2 (8.42 - 12.30) 1995 Modelled IHME
10.1 (8.35 - 12.10) 1994 Modelled IHME
10 (8.27 - 12.20) 1993 Modelled IHME
10 (8.23 - 12.20) 1992 Modelled IHME
10 (8.21 - 12.20) 1991 Modelled IHME
9.95 (8.11 - 12.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4,817 (4,031 - 5,638) 2019 Modelled IHME
4,785 (3,988 - 5,614) 2018 Modelled IHME
4,762 (3,942 - 5,616) 2017 Modelled IHME
4,743 (3,961 - 5,569) 2016 Modelled IHME
4,755 (3,966 - 5,580) 2015 Modelled IHME
4,679 (3,914 - 5,476) 2014 Modelled IHME
4,653 (3,894 - 5,447) 2013 Modelled IHME
4,671 (3,905 - 5,460) 2012 Modelled IHME
4,637 (3,872 - 5,434) 2011 Modelled IHME
4,594 (3,834 - 5,385) 2010 Modelled IHME
4,601 (3,840 - 5,400) 2009 Modelled IHME
4,595 (3,827 - 5,399) 2008 Modelled IHME
4,583 (3,798 - 5,393) 2007 Modelled IHME
4,543 (3,764 - 5,370) 2006 Modelled IHME
4,565 (3,804 - 5,407) 2005 Modelled IHME
4,553 (3,790 - 5,396) 2004 Modelled IHME
4,523 (3,762 - 5,383) 2003 Modelled IHME
4,412 (3,671 - 5,253) 2002 Modelled IHME
4,303 (3,565 - 5,123) 2001 Modelled IHME
4,240 (3,509 - 5,062) 2000 Modelled IHME
4,247 (3,528 - 5,074) 1999 Modelled IHME
4,162 (3,465 - 4,977) 1998 Modelled IHME
4,089 (3,403 - 4,905) 1997 Modelled IHME
4,085 (3,366 - 4,908) 1996 Modelled IHME
4,017 (3,312 - 4,830) 1995 Modelled IHME
3,954 (3,273 - 4,759) 1994 Modelled IHME
3,920 (3,231 - 4,750) 1993 Modelled IHME
3,902 (3,208 - 4,760) 1992 Modelled IHME
3,901 (3,190 - 4,744) 1991 Modelled IHME
3,858 (3,145 - 4,726) 1990 Modelled IHME
4,316 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
55 (45 - 65) 2019 Modelled IHME
55 (45 - 65) 2018 Modelled IHME
55 (45 - 65) 2017 Modelled IHME
55 (45 - 65) 2016 Modelled IHME
55 (44 - 65) 2015 Modelled IHME
55 (44 - 65) 2014 Modelled IHME
55 (44 - 65) 2013 Modelled IHME
55 (44 - 64) 2012 Modelled IHME
55 (44 - 64) 2011 Modelled IHME
54 (44 - 64) 2010 Modelled IHME
54 (44 - 64) 2009 Modelled IHME
54 (43 - 63) 2008 Modelled IHME
53 (43 - 63) 2007 Modelled IHME
53 (42 - 62) 2006 Modelled IHME
52 (42 - 62) 2005 Modelled IHME
52 (42 - 62) 2004 Modelled IHME
52 (42 - 62) 2003 Modelled IHME
52 (41 - 62) 2002 Modelled IHME
52 (41 - 62) 2001 Modelled IHME
52 (41 - 62) 2000 Modelled IHME
52 (41 - 62) 1999 Modelled IHME
52 (41 - 62) 1998 Modelled IHME
51 (41 - 62) 1997 Modelled IHME
51 (40 - 61) 1996 Modelled IHME
51 (40 - 61) 1995 Modelled IHME
51 (40 - 61) 1994 Modelled IHME
51 (40 - 61) 1993 Modelled IHME
50 (40 - 61) 1992 Modelled IHME
50 (40 - 61) 1991 Modelled IHME
50 (41 - 61) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 2016 Survey/reported EMCDDA, 2019
141 (84 - 428) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
Yes
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.75 (%)
2019
(0.67 - 0.83(%))
IHME
HCV (RNA/cAg+)
0.98 (%)
2019
(0.79 - 1.18(%))
IHME

Survey/surveillance

HBV (HBsAg+)
0.7 (%)
2009
(0.5 - 1(%))
Pedraza-Flechas et al, 2014
HCV (anti-HCV)
0.4 (%)
2015
(0 - 2.3(%))
Garcia-Alonso, 2016

Hepatitis related deaths (national)

Modelled

HBV
954
2019
(732 - 1,212)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4,817
2019
(4,031 - 5,638)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.03 (%)
2019, latest modelled
(0.02 - 0.04(%))
IHME

Prevalence PWID

HCV
71 (%)
2012, latest modelled
(69.50 - 72.50(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
119
2016
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Action plan

View all

Action plans

Resources